Benzbromarone
As of the edition of 20 October 2026, Benzbromarone is a small molecule: marketed, first approved in 1971 (ES); acts on SLC22A12.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1971
- Kind
- Small molecule
- Brand name
- Urinorm
- First approved
- 1 June 1971 (ES)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Evolan Pharma Ab
- Withdrawn from market
- 1 January 2003 (in some regions)
- Registered trials
- 6, 0 stopped early
- Disease areas
- Nutrition and metabolism; Pregnancy and women's health; Urinary and reproductive; Bones, joints and muscles; Heart and blood vessels; Hormones
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| SLC22A12 | Solute carrier family 22 member 12 | Q96S37 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 1 | 0 | 0 |
| Phase 2 | 2 | 2 | 0 | 0 |
| Phase 4 | 2 | 2 | 0 | 0 |
| All trials | 6 |